A 34-year-old man with progressive behavioral and language disturbance

Neurology

Volumn 68, Issue 1, 2007, Pages 68-74

  Miller, Bruce L ^a   Josephs Jr , Keith A ^b   Parisi, Joseph E ^b   Keegan, B Mark ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLOZAPINE; DEXAMPHETAMINE; ESCITALOPRAM; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; ANAMNESIS; AUTOPSY; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; COGNITION; CONFERENCE PAPER; DEATH; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LANGUAGE DISABILITY; MALE; MANIA; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PERSONAL HYGIENE; PERSONALITY DISORDER; PRIORITY JOURNAL; SOCIAL ISOLATION;

ADULT; DEMENTIA; FATAL OUTCOME; HUMANS; LANGUAGE DISORDERS; MALE; MENTAL DISORDERS;

EID: 33846079564     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000251313.89403.b3     Document Type: Conference Paper

References (24)

1. Rankin K, Kramer JH, Mychack P, Miller BL. Double dissociation of social functioning in frontotemporal dementia. Neurology 2003;60:266-271.
2. Rosen HJ, Allison S, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioral disorders in dementia. Brain 2005;128:2612-2625.
3. Gorno-Tempini ML, Ogar JM, Brambati SM, et al. Anatomical correlates of early mutism in progressive nonfluent aphasia. Neurology 2006;67:1849-1851.
4. Josephson SA, Schmidt RE, Millsap P, McManus DQ, Morris JC. Autosomal dominant Kufs' disease: a cause of early onset dementia. J Neurol Sci 2001;188:51-60.
5. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1552.
6. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-1621.
7. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005;65:719-725.
8. Goldman J, Farmer JM, Wood BM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005;65:1817-1819.
9. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377-381.
10. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-808.
11. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
12. Bugiani O, Murrell JR, Giaccone G, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999;58:667-677.
13. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-919.
14. Cruts M, Guselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442:920-924.
15. Lipton AM, White CL, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004;108:379-385.
16. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
17. Cairns NJ, Grossman M, Arnold SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004;63:1376-1384.
18. Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan J. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990;40:251-256.
19. Whitwell JL, Jack CR, Senjem ML, Josephs K. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 2006;66:102-104.
20. Lowe J, Rossor MN. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel, Switzerland: ISN Neuropath Press, 2003:342-348.
21. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809.
22. Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 2006;63:506-512.
23. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-1352.
24. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.